Focusing on Helicobacter pylori infection in the elderly

被引:6
|
作者
Gong, Hang [1 ]
Xu, Hui-Mei [1 ]
Zhang, De-Kui [1 ]
机构
[1] Lanzhou Univ Second Hosp, Dept Gastroenterol, Lanzhou, Gansu, Peoples R China
关键词
Helicobacter pylori; eradication therapy; elderly; side effect; drug resistance; STANDARD TRIPLE THERAPY; C-13-UREA BREATH TEST; STOOL ANTIGEN TEST; CHRONIC ATROPHIC GASTRITIS; RANDOMIZED CLINICAL-TRIAL; DRUG-DRUG INTERACTION; DOSE DUAL THERAPY; SEQUENTIAL THERAPY; PEPTIC-ULCER; ANTIBIOTIC-RESISTANCE;
D O I
10.3389/fcimb.2023.1121947
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
As a confirmed carcinogen, Helicobacter pylori (H. pylori) is the main cause of inflammatory diseases of the upper digestive tract and even gastric cancer. There is a high prevalence of H. pylori infection among the elderly population, which may cause adverse clinical outcomes. Particularly noteworthy is that guidelines or expert consensus presently available on H. pylori infection overlook the management of the elderly population as a special group. A brief overview of H. pylori in the elderly is as follows. The detection of H. pylori infection can be divided into invasive and non-invasive techniques, and each technique has its advantages and shortcomings. There may be more side effects associated with eradication treatment in elderly individuals, especially for the frail population. Physical conditions and risk-benefit assessments of the elderly should be considered when selecting therapeutic strategies for H. pylori eradication. Unless there are competing factors, elderly patients should receive H. pylori eradication regimens to finally reduce the formation of gastric cancer. In this review, we summarize the latest understanding of H. pylori in the elderly population to provide effective managements and treatment measures.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Helicobacter pylori Infection
    Cho, Jaehoon
    Prashar, Akriti
    Jones, Nicola L.
    Moss, Steven F.
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2021, 50 (02) : 261 - 282
  • [32] Helicobacter pylori Infection
    Hsu, Ping-I
    Yamaoka, Yoshio
    Goh, Khean-Lee
    Manfredi, Marco
    Wu, Deng-Chyang
    Mahachai, Varocha
    BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [33] Helicobacter pylori infection
    Vandenplas Y
    World Journal of Gastroenterology, 2000, 6 (01) : 20 - 31
  • [34] Helicobacter pylori infection
    Harris, A
    Danesh, J
    Forman, D
    LANCET, 1997, 349 (9055): : 879 - 880
  • [35] Helicobacter pylori infection
    García, JMP
    REVISTA CLINICA ESPANOLA, 2002, 202 (02): : 99 - 110
  • [36] Helicobacter pylori infection
    Hughes, WT
    PEDIATRIC ANNALS, 1996, 25 (09): : 491 - 493
  • [37] Helicobacter pylori infection
    Goodwin, CS
    Mendall, MM
    Northfield, TC
    LANCET, 1997, 349 (9047): : 265 - 269
  • [38] Helicobacter pylori infection
    Malfertheiner, Peter
    Camargo, M. Constanza
    El-Omar, Emad
    Liou, Jyh-Ming
    Peek, Richard
    Schulz, Christian
    Smith, Stella I.
    Suerbaum, Sebastian
    NATURE REVIEWS DISEASE PRIMERS, 2023, 9 (01)
  • [39] Helicobacter pylori infection
    Peter Malfertheiner
    M. Constanza Camargo
    Emad El-Omar
    Jyh-Ming Liou
    Richard Peek
    Christian Schulz
    Stella I. Smith
    Sebastian Suerbaum
    Nature Reviews Disease Primers, 9 (1)
  • [40] Helicobacter pylori Infection
    McColl, Kenneth E. L.
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (17): : 1597 - 1604